Showing results (101-110 of 188) with videos related to
Sort By:
Pageof 19
The Pharmacogenomics Journal|April 19, 2007
Hepatocyte nuclear factor-1 alpha is associated with UGT1A1, UGT1A9 and UGT2B7 mRNA expression in human liverJ Ramírez, S Mirkov, W Zhang, et al.Cancer|July 1, 1994
A phase I study of intermittent infusion cladribine in patients with solid tumorsK Kobayashi, N J Vogelzang, S M O'Brien, et al.Journal of the National Cancer Institute|August 2, 1989
Low-dose interferon alfa-2b in the treatment of hairy cell leukemiaJ A Moormeier, M J Ratain, C A Westbrook, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062)A A Miller, G L Rosner, M J Ratain, et al.American Journal of Clinical Pathology|September 1, 1988
Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase techniqueJ W Vardiman, T A Gilewski, M J Ratain, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findingsM E Dolan, S K Roy, A A Fasanmade, et al.Cancer Research|May 15, 1993
Phase I study of amonafide dosing based on acetylator phenotypeM J Ratain, R Mick, F Berezin, et al.The Pharmacogenomics Journal|November 16, 2016
ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropeniaM Li, E L Seiser, R M Baldwin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2002
Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumorsC Eng, A M Mauer, G F Fleming, et al.Cancer Research|June 1, 1989
A limited sampling strategy for cyclophosphamide pharmacokineticsM J Egorin, A Forrest, C P Belani, et al.Pageof 19